2 weeks Vertex Pharmaceuticals (VRTX) Misses Q4 Earnings Estimates Zacks

Vertex (VRTX) delivered earnings and revenue surprises of -0.25% and 5.16%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?